How ongoing care shapes GLP-1 outcomes 2x Longer on therapy Ongoing support keeps patients on GLP-1s 2x longer, maximizing long-term benefits 9+ Systems affected GLP-1s influence brain, heart, kidney, & more
They can explain the long-term treatment process, benefits, potential risks, and what to do with individuals planning Saxenda stopping or restarting treatments
Details: BPC-157 Peptide BPC 157, a pentadecapeptide found in the gastric system or stomach has been demonstrated when supplemented to promote the healing of different tissues, including skin, muscle, bone, ligament and tendons
Not Sci Biol 13(2):1089410894
We find that ACSL4-knocked-down A549 cells are resistant to Bet v 1-induced ferroptosis and have lower levels of lipid ROS, suggesting that ACSL4 sensitizes AT II cells to ferroptosis, which also corroborates previous studies [12]
Or why isn't it on the other side dropping my basal metabolic rate so now I'm still gaining weight, or I'm staying at a sort of consistent level even at this lower calorie intake that the GLP-1 is allowing for me to have